Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2025

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

Presenter: Ahmed A. Mahmoud

October 28, 2025

Presentation TCT 2025

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 801: Comparative Efficacy and Safety of Beta Blockers Versus SGLT2 Inhibitors in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Priyesh Thakurathi

October 27, 2025

Presentation TCT 2025

TCT 755: Impact of SGLT2 Inhibitors on Outcomes After TAVR: A Real-World Propensity-Matched Analysis

Presenter: Salman Zahid

October 27, 2025

Presentation TCT 2025

TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis

Presenter: Mahmoud Abdelnabi

October 25, 2025

Presentation TCT 2025

TCT 749: Renal Protective Effects of SGLT2 Inhibitors After Transcatheter Mitral Valve Repair in Patients with Type 2 Diabetes Mellitus: A Propensity-Matched Retrospective Analysis

Presenter: Mahmoud Abdelnabi

October 25, 2025

Advertisement

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

TCT 801: Comparative Efficacy and Safety of Beta Blockers Versus SGLT2 Inhibitors in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 755: Impact of SGLT2 Inhibitors on Outcomes After TAVR: A Real-World Propensity-Matched Analysis

TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis

TCT 749: Renal Protective Effects of SGLT2 Inhibitors After Transcatheter Mitral Valve Repair in Patients with Type 2 Diabetes Mellitus: A Propensity-Matched Retrospective Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content